Topics
Glioblastoma | Treatment | Targeted therapy | Pexidartinib
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Pexidartinib
Mendez JS, Cohen AL, Eckenstein M, Jensen RL, Burt LM, Salzman KL,
Chamberlain M, Hsu HH, Hutchinson M, Iwamoto F, Ligon KL, Mrugala
MM, Pelayo M, Plotkin SR, Puduvalli VK, Raizer J, Reardon DA,
Sterba M, Walbert T, West BL, Wong ET, Zhang C, Colman H.
Phase
1b/2 study of orally administered pexidartinib in combination with
radiation therapy and temozolomide in patients with newly
diagnosed glioblastoma.
Neurooncol
Adv. 2024 Nov 22;6(1):vdae202. doi:
10.1093/noajnl/vdae202. PMID:
39734810. Interventional study. ˍ